Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Kits > IL-23 > EP-167

IL-23 : IL-23R[Biotinylated] Inhibitor Screening ELISA Kit

For research use only.

Order Now

  • Background
    Interleukin-23 subunit alpha (IL-23 alpha) can associates with IL12B to form the IL-23 interleukin, a heterodimeric cytokine which functions in innate and adaptive immunity. IL-23 may constitute with IL-17 an acute response to infection in peripheral tissues. IL-23 binds to a heterodimeric receptor complex composed of IL12RB1 and IL23R, activates the Jak-Stat signaling cascade, stimulates memory rather than naive T-cells and promotes production of proinflammatory cytokines. IL-23 induces autoimmune inflammation and thus may be responsible for autoimmune inflammatory diseases and may be important for tumorigenesis.
  • Application

    This kit is developed for screening for inhibitors of human IL-23 binding to human IL-23R.

    It is for research use only.

  • Reconstitution
    Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.
  • Storage
    Unopened kit should be stored at 2°C-8°C upon receiving. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • Assay Principles
    This inhibitor screening ELISA kit is designed to facilitate the identification and characterization of new Human IL-23 pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated Human IL-23R to immobilized Human IL-23 in a functional ELISA assay and employs a simple colorimetric ELISA platform. Briefly, we provide you with a Human IL-23A&IL-12B protein, a Biotinylated Human IL-23R, an anti- IL-23A neutralizing antibody (as method verified Std.), and Streptavidin-HRP reagent.

    Your experiment will include 4 simple steps:

    1) Coat the plate with Human IL-23A&IL-12B.

    2) Add your molecule of interest to the tests.

    3) Add Human IL-23R-Biotin to bind the coated Human IL-23A&IL-12B.

    4) Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.

    Finally, the half maximal inhibitory concentration (IC50) of your compound to Human IL-23A: Human IL-23R

    binding will be determined by comparing OD readings among different experimental groups.

Typical Data Please refer to Ds document for the assay protocol.
 IL-23 TYPICAL DATA

Serial dilutions of Anti-IL23A Neutralizing antibody (Catalog # EP167-C04) (1:1 serial dilution, from 10μg/mL to 0.000976563μg/mL) was added into Human IL-23A&IL-12B: Biotinylated Human IL-23 R binding reactions. The assay was performed according to the protocol described below. Background was subtracted from data points prior to log transformation and curve fitting (QC tested).

  • Clinical and Translational Updates

Comments (0)

Promotion & Exhibitions



Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message